title: [Acute ST-elevation myocardial infarction in the elderly (>75 years). Results from a regional multicenter study].
abstract: OBJECTIVE
  This prospective multicenter study assessed the prevalence and feasibility of percutaneous coronary angioplasty (PTCA) in the acute phase of ST-elevation myocardial infarction (STEMI) in 3 nonacademic interventional cardiology centers (Alsace, France).
  
  
  METHODS
  We studied the clinical characteristics, angiographic data, and PCTA results of all STEMI patients and analyzed the revascularization rates and adverse events during hospitalization. We compared patients at least 75 years of age and younger patients for these data and with the literature.
  
  
  RESULTS
  Of the 1672 patients admitted for STEMI, 342 (20.45%) were at least 75 years of age. Half the patients in this high-risk subgroup were women. These patients had more co-morbidities (e.g., hypertension and diabetes mellitus) than younger patients, and more of them had three-vessel disease. Mortality rate was high in this subgroup and always higher than for comparable younger subjects, but it varied according to the initial clinical profile. Their global mortality rate was 20.47%, but it fell to 5.41% when we excluded patients with cardiogenic shock or in Killip stage ill, and those who were resuscitated. PTCA is a coronary reperfusion technique especially indicated for elderly patients with STEMI. It is an effective revascularization technique, with a reperfusion rate (exclusively TIMI III flow) reaching 93.88% in the elderly group, only slightly lower than among younger patients (97.18%).
  
  
  CONCLUSIONS
  PTCA is a technique particularly indicated in the elderly in Alsace because of regional geographic and medical specificities: nearby emergency services are available to virtually the entire population of Alsace, and most interventional cardiology teams apply a strategy of exclusive primary PTCA.
authors.affiliation: USIC, Groupe hospitalier privé du Centre Alsace, Clinique Saint-Joseph, Colmar. gaetan.dangelser@hotmail.com
authors.forename: G
authors.initials: G
authors.lastname: Dangelser
authors.forename: Y
authors.initials: Y
authors.lastname: Gottwalles
authors.forename: M
authors.initials: M
authors.lastname: Huk
authors.forename: F
authors.initials: F
authors.lastname: de Poli
authors.forename: L
authors.initials: L
authors.lastname: Levai
authors.forename: J-M
authors.initials: JM
authors.lastname: Boulenc
authors.forename: J-P
authors.initials: JP
authors.lastname: Monassier
authors.forename: L
authors.initials: L
authors.lastname: Jacquemin
authors.forename: P
authors.initials: P
authors.lastname: Couppie
authors.forename: M
authors.initials: M
authors.lastname: Hanssen
mesh_terms: D000367:Age Factors; D000368:Aged; D000369:Aged, 80 and over; D015906:Angioplasty, Balloon, Coronary; D017023:Coronary Angiography; D004562:Electrocardiography; D005240:Feasibility Studies; D005260:Female; D005602:France; D017052:Hospital Mortality; D006801:Humans; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000175:diagnosis / Q000000981:diagnostic imaging / Q000401:mortality / Q000628:therapy*; D011446:Prospective Studies; D012307:Risk Factors; D012737:Sex Factors; D013997:Time Factors; D016896:Treatment Outcome